Search

Your search keyword '"Redfors B"' showing total 251 results

Search Constraints

Start Over You searched for: Author "Redfors B" Remove constraint Author: "Redfors B" Search Limiters Full Text Remove constraint Search Limiters: Full Text
251 results on '"Redfors B"'

Search Results

1. PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve

2. Stress-induced cardiomyopathy (Takotsubo) – broken heart and mind?

3. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints

4. Importance of hospital and clinical factors in predicting of 30-day mortality in Takotsubo syndrome: data from the Swedish Coronary Angiography and Angioplasty Registry

5. Temporal proteomic and phosphoproteomic profiling of the left ventricle in a novel rat model of ischemia/reperfusion with or without ischemic preconditioning

6. Impact of COVID-19 pandemics on the incidence and mortality in Takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry

7. Importance of hospital and clinical factors in predicting of 30-day mortality in Takotsubo syndrome : data from the Swedish Coronary Angiography and Angioplasty Registry

8. Impact of COVID-19 pandemics on the incidence and mortality in Takotsubo syndrome : a report from Swedish Coronary Angiography and Angioplasty Registry

9. Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?

11. Early changes in myocardial stunning and biomarkers after ST-elevation myocardial infarction compared to the takotsubo syndrome

13. Maximally tolerated guideline-directed medical therapy and barriers to optimization in patients with heart failure with reduced ejection fraction: the COAPT trial

14. Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology – Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications

15. ECMO for COVID-19 patients in Europe and Israel

16. ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016

17. Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?

18. Cerebrovascular events after transcatheter mitral valve repair or guideline-directed medical therapy in patients with mitral regurgitation and heart failure in the COAPT trial

20. Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction : Sex-related outcomes from DETO2X-AMI

21. Long-term survival in patients with coronary artery disease undergoing percutaneous coronary intervention with or without intracoronary pressure wire guidance : a report from SCAAR

24. Comparative Effectiveness of CABG versus PCI in Patients with Ischemic Heart Disease: insights from SWEDEHEART Registry

25. Long-term survival in patients with coronary artery disease undergoing percutaneous coronary intervention with or without intracoronary pressure wire guidance: a report from SCAAR

27. Regional differences in the incidence and prognosis of the takotsubo syndrome

28. Incidence and prognosis of the takotsubo syndrome compared to acute myocardial infarction

29. Regional differences in the incidence and outcome of acute ischemic heart failure after ST-elevation myocardial infarction in Sweden

30. Incidence and outcome of takotsubo syndrome compared to acute myocardial infarction, in men versus women

31. [Accepted Manuscript] Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial

33. P1966Impact of coronary artery calcification on long-term outcomes after implantation of first and second-generation drug-eluting stents: a patient-level analysis of 18 randomized trials

34. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease

35. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial

36. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

37. P4667Relationships between cigarette smoking, infarct size, and clinical outcomes in patients undergoing primary PCI For STEMI: a patient-level pooled analysis of 10 randomized trials

43. ESICM LIVES 2016: part three

44. Targeting filamin A reduces K-RAS–induced lung adenocarcinomas and endothelial response to tumor growth in mice

45. Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology – Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications

46. ECMO for COVID-19 patients in Europe and Israel

47. Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 1: overview and the central role for catecholamines and sympathetic nervous system

48. Effects of acute plasma volume expansion on renal perfusion, filtration, and oxygenation after cardiac surgery: a randomized study on crystalloid vs colloid.

49. Takotsubo syndrome and McConnell's phenomenon

50. Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents: 5-Year Outcomes From the BIONICS and NIREUS Trials.

Catalog

Books, media, physical & digital resources